BBIO: BridgeBio Pharma Inc
BBIO exchange rate has changed by -1.22% for today. During the day, the instrument was traded at a low of 63.6250 and at a high of 66.0500.
Follow BridgeBio Pharma Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BBIO News
- BridgeBio Pharma director Ellis Andrea sells $4.2m in shares
- BridgeBio to present LGMD2I/R9 trial data at MDA conference
- Ascendis Pharma: Yuviwel Approved Despite Legal Challenges (NASDAQ:ASND)
- Ionis Pharmaceuticals Stock: Digesting Recent Events (NASDAQ:IONS)
- BridgeBio Pharma (BBIO) Reports Q4 Loss, Beats Revenue Estimates
- BridgeBio rises on revenue beat despite wider loss
- BridgeBio Pharma earnings missed by $0.28, revenue topped estimates
- Blue Owl, Genuine Parts, And Okta Are Among Top 10 Large Cap Losers Last Week (Feb. 16-Feb. 20): Are the Others in Your Portfolio? - BridgeBio Pharma (NASDAQ:BBIO), BorgWarner (NYSE:BWA), Expedia Group (NASDAQ:EXPE), Flutter Entertainment (NYSE:FLUT)
- Bausch Health (BHC) Q4 Earnings Lag Estimates
- BridgeBio Pharma CAO Apuli sells $37898 in BBIO stock
- BridgeBio Pharma director Scott sells $754k in BBIO stock
- BridgeBio earnings up next: Can pipeline wins fuel growth?
- Earnings Preview: Supernus Pharmaceuticals (SUPN) Q4 Earnings Expected to Decline
- Allspring Growth Fund Q4 2025 Fund Performers And Detractors
- BridgeBio Pharma, Inc. (BBIO) Discusses Positive Phase 3 PROPEL 3 Results for Infigratinib in Children With Achondroplasia Transcript
- BridgeBio Unveils Positive Results For Its Most 'Hotly Debated' Phase 3 Drug
- BridgeBio Pharma, Inc. (BBIO) Discusses Positive Phase 3 PROPEL 3 Results for Infigratinib in Children With Achondroplasia - Slideshow (NASDAQ:BBIO) 2026-02-12
Frequently Asked Questions
What is BBIO stock price today?
BridgeBio Pharma Inc stock is priced at 65.3600 today. It trades within 63.6250 - 66.0500, yesterday's close was 66.1700, and trading volume reached 4153. The live price chart of BBIO shows these updates.
Does BridgeBio Pharma Inc stock pay dividends?
BridgeBio Pharma Inc is currently valued at 65.3600. Dividend policy depends on the company, while investors also watch 14.67% and USD. View the chart live to track BBIO movements.
How to buy BBIO stock?
You can buy BridgeBio Pharma Inc shares at the current price of 65.3600. Orders are usually placed near 65.3600 or 65.3630, while 4153 and 1.47% show market activity. Follow BBIO updates on the live chart today.
How to invest into BBIO stock?
Investing in BridgeBio Pharma Inc involves considering the yearly range 56.7400 - 84.9400 and current price 65.3600. Many compare 1.55% and 14.67% before placing orders at 65.3600 or 65.3630. Explore the BBIO price chart live with daily changes.
What are BridgeBio Pharma Inc stock highest prices?
The highest price of BridgeBio Pharma Inc in the past year was 84.9400. Within 56.7400 - 84.9400, the stock fluctuated notably, and comparing with 66.1700 helps spot resistance levels. Track BridgeBio Pharma Inc performance using the live chart.
What are BridgeBio Pharma Inc stock lowest prices?
The lowest price of BridgeBio Pharma Inc (BBIO) over the year was 56.7400. Comparing it with the current 65.3600 and 56.7400 - 84.9400 shows potential long-term entry points. Watch BBIO moves on the chart live for more details.
When did BBIO stock split?
BridgeBio Pharma Inc has gone through stock splits historically. These changes are visible in , 66.1700, and 14.67% after corporate actions.
- Previous Close
- 66.1700
- Open
- 64.4100
- Bid
- 65.3600
- Ask
- 65.3630
- Low
- 63.6250
- High
- 66.0500
- Volume
- 4.153 K
- Daily Change
- -1.22%
- Month Change
- 1.55%
- 6 Months Change
- 14.67%
- Year Change
- 14.67%